LivaNova (LIVN) Amortization of Deferred Charges (2020 - 2026)
LivaNova's (LIVN) quarterly Amortization of Deferred Charges came in at $4.9 million in Q2 2026, down 14.04% year-over-year from $5.7 million in Q2 2025, and up 2.08% quarter-over-quarter from $4.8 million in Q1 2026.
Analysis
LivaNova (LIVN) Amortization of Deferred Charges (2020 - 2026) Analysis & Trends
LivaNova has disclosed Amortization of Deferred Charges across 7 years of filings, most recently posting $4.9 million for Q2 2026.
- In Q2 2026, Amortization of Deferred Charges fell 14.04% year-over-year to $4.9 million; the TTM figure through Jun 2026 stood at $21.4 million (down 6.14% YoY), while the FY2025 annual figure was $23.1 million, up 6.94% from the prior year.
- Amortization of Deferred Charges came in at $4.9 million for Q2 2026 at LivaNova, up from $4.8 million in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $5.9 million in Q4 2024 to a low of $3.5 million in Q2 2022.
- Average Amortization of Deferred Charges over 5 years is $5.0 million, with a median of $4.9 million recorded in 2022.
- Year-over-year, Amortization of Deferred Charges jumped 38.38% in 2022 and fell 15.79% in 2026.
- Over 5 years, Amortization of Deferred Charges stood at $4.9 million in 2022, then dropped by 1.74% to $4.9 million in 2023, then advanced by 21.55% to $5.9 million in 2024, then retreated by 1.69% to $5.8 million in 2025, then declined by 15.52% to $4.9 million in 2026.
- Per Business Quant data, the three most recent Amortization of Deferred Charges figures were $4.9 million in Q2 2026, $4.8 million in Q1 2026, and $5.8 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | LivaNova | 4.34 Bn | 3.82 Bn | 273.67 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.90 Mn |
| Mar 31, 2026 | 4.80 Mn |
| Dec 31, 2025 | 5.80 Mn |
| Sep 30, 2025 | 5.90 Mn |
| Jun 30, 2025 | 5.70 Mn |
| Mar 31, 2025 | 5.70 Mn |
| Dec 31, 2024 | 5.90 Mn |
| Sep 30, 2024 | 5.50 Mn |
| Jun 30, 2024 | 5.30 Mn |
| Mar 31, 2024 | 4.90 Mn |
| Dec 31, 2023 | 4.85 Mn |
| Sep 30, 2023 | 4.70 Mn |
| Jun 30, 2023 | 3.90 Mn |
| Mar 31, 2023 | 5.02 Mn |
| Dec 31, 2022 | 4.94 Mn |
| Sep 30, 2022 | 3.70 Mn |
| Jun 30, 2022 | 3.50 Mn |
| Mar 31, 2022 | 4.41 Mn |
| Dec 31, 2021 | 3.57 Mn |
| Sep 30, 2021 | 3.30 Mn |